CFAP92
Uncharacterized protein CFAP92
Also known as: CFA92_HUMAN, FAP92, FLJ43738, KIAA1257
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULG3
- Gene
- CFAP92
- Ensembl
- ENSG00000114656
- Chromosome
- 3
- Canonical length
- 409 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for CFAP92 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
409 residues, UniProt reviewed canonical sequence.
>Q9ULG3|CFAP92
1 MSLHAWEWEE DPASIEPISS ITSFYQSTSE CDVEEHLKAK ARAQESDSDR PCSSIESSSE
61 PASTFSSDVP HVVPCKFTIS LAFPVNMGQK GKYASLIEKY KKHPKTDSSV TKMRRFYHIE
121 YFLLPDDEEP KKVDILLFPM VAKVFLESGV KTVKPWHEGD KAWVSWEQTF NITVTKELLK
181 KINFHKITLR LWNTKDKMSR KVRYYRLKTA GFTDDVGAFH KSEVRHLVLN QRKLSEQGIE
241 NTNIVREESN QEHPPGKQEK TEKHPKSLQG SHQAEPETSS KNSEEYEKSL KMDDSSTIQW
301 SVSRTPTISL AGASMMEIKE LIESESLSSL TNILDRQRSQ IKGKDSEGRR KIQRRHKKPL
361 AEEEADPTLT GPRKQSAFSI QLAVMPLLAG THCLPCSQQL LLVLWPERPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CFAP92 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- testis: 24 nTPM
- choroid plexus: 4.3 nTPM
- pituitary gland: 4.1 nTPM
- skin: 4.1 nTPM
- thymus: 3.8 nTPM
- fallopian tube: 3.1 nTPM
Single-cell type
- late spermatids: 321 nCPM
- early spermatids: 209 nCPM
- late primary spermatocytes: 205 nCPM
- ependymal cells: 148 nCPM
- epicardial cells: 146 nCPM
- respiratory ciliated cells: 90 nCPM
Immune cell
- neutrophil: 34 nTPM
- eosinophil: 2.9 nTPM
- basophil: 0.8 nTPM
- classical monocyte: 0.7 nTPM
- naive CD8 T-cell: 0.5 nTPM
- memory B-cell: 0.4 nTPM
Brain region
- midbrain: 21 nTPM
- choroid plexus: 20 nTPM
- cerebellum: 19 nTPM
- hippocampal formation: 18 nTPM
- medulla oblongata: 18 nTPM
- hypothalamus: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Domain of unknown function DUF4550
- Domain of unknown function (DUF4550)
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CFAP92 as an antibody target. Whether an autoantibody or antibody against CFAP92 could matter depends on whether native CFAP92 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CFAP92 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CFAP92 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...